1.Effect of basal serum luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio on outcomes of in vitro fertilization-embryo transfer in patients with polycystic ovarian syndrome.
Xujing GENG ; Xianghong OU ; Yixin LIAO ; Wenya TAN ; Song WANG ; Song QUAN
Journal of Southern Medical University 2013;33(6):857-860
OBJECTIVETo evaluate the effect of basal serum luteinizing hormone (LH) and luteinizing hormone/follicle-stimulating hormone (LH/FSH) ratio on the clinical outcomes of in vitro fertilization-embryo transfer (IVF-ET) in patients with polycystic ovary syndrome (PCOS).
METHODSA retrospective analysis was performed of 134 IVF cycles in patients with PCOS. The cycles were classified into 2 groups according to serum levels of LH and also into 2 groups according to LH/FSH ratio, namely group A1 (LH≤10 IU/L), group A2 (LH>10 IU/L), group B1 (LH/FSH ratio<2), and group B2 (LH/FSH ratio≥2). The clinical characteristics, embryological data and pregnancy outcomes were compared between the groups.
RESULTSPatients in group A2 showed significantly higher FSH, T level, and LH/FSH ratio with a greater number of oocytes retrieved than those in group A1, but the time for down-regulation, duration of stimulation, AFC, LH and LH/FSH on the first day of stimulation, embryological data and pregnancy outcomes did not differ significantly between the two groups. Compared with group B1, group B2 showed higher basal LH, E2 level on the day of HCG, more oocytes retrieved and lower dose of gonadotropins used, but the time for down-regulation, duration of stimulation, LH and LH/FSH on the first day of stimulation and pregnancy outcomes were comparable between the two groups.
CONCLUSIONA high basal LH level or a high LH/FSH ratio does not produce obvious deleterious effect on the clinical outcomes of IVF-ET in women with PCOS who take oral contraceptives for pretreatment before long GnRH-agonist protocol.
Adult ; Female ; Fertilization in Vitro ; methods ; Follicle Stimulating Hormone ; blood ; Humans ; Luteinizing Hormone ; blood ; Polycystic Ovary Syndrome ; blood ; Pregnancy ; Pregnancy Rate ; Retrospective Studies
2.Analysis of the Correlations between the Levels of HIF-1α,AQP9 and the Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
Xujing CHEN ; Hongyan GENG ; Xinjing LIU
Journal of Apoplexy and Nervous Diseases 2020;37(3):227-231
Objective To explore the correlations between serum hypoxia inducible factor-1α (HIF-1α),aquaporin-9 (AQP9) and hemorrhagic transformation (HT) in patients with acute ischemic stroke (AIS) and its clinical significance. Methods 183 newly diagnosed patients with acute AIS from October 2017 to April 2019 were divided into HT group (n=84) and non HT group (n=99),the baseline data of gender,age,body mass index (BMI),proportions of hypertension,diabetes,hyperlipidemia,the baseline NIHSS score,baseline systolic blood pressure,baseline diastolic blood pressure,baseline blood glucose,thrombolytic time window and serum samples were collected. The expressions of HIF-1α and AQP9 proteins were detected by Western blot (WB);Pearson’s method was used to analyze the correlation between HIF-1α and AQP9 levels in patients with AIS in HT group;the risk factors of HT in AIS patients were analyzed by logistic regression;Using NIHSS score,thrombolysis time window,serum HIF-1α,AQP9 levels as independent variables,the working characteristic curve (ROC) of subjects was drawn to analyze the predictive value of HT in AIS patients. Results Compared with the non HT group,the baseline NIHSS score,baseline systolic blood pressure,baseline diastolic blood pressure,baseline blood glucose,thrombolytic time window,serum HIF-1α,AQP9 levels of AIS patients in HT group were significantly higher (P<0.05). There was a positive correlation between the levels of HIF-1α and AQP9 proteins in patients with AIS in HT group (r=0.679,P<0.05). NIHSS score,thrombolysis time window and serum HIF-1α,AQP9 protein levels were independent risk factors for HT in AIS patients after thrombolysis (P<0.05). The AUCs of NIHSS score,thrombolysis time window,serum HIF-1α and AQP9 in the diagnosis of HT in AIS patients were 0.707,0.790,0.881 and 0.869 respectively,the cutoff values were 13.39 points,296.31 min,0.33 and 0.32 respectively,the sensitivities were 44%,66.70%,86.90% and 83.30% respectively,and the specificities were 91.90%,87.90%,87.90% and 88.90% respectively. The AUC of the combination of four methods in the diagnosis of HT in AIS patients was 0.980,the sensitivity and specificity were 94.00% and 94.90%,respectively,and the diagnostic efficiency of the four methods was significantly higher than that of single index. Conclusion The elevated levels of HIF-1α and AQP9 were closely related to the occurrence of HT in AIS patients,and the combination of NIHSS score and thrombolysis time window could significantly improve the predictive value of HT in AIS,which may have some clinical reference significance.